Integrated Diagnostics Holdings

IDHC · Main Market · Health Care · mcap £231m · 39.7p

Beta Briefing, track record and signals & risks are not ready for Integrated Diagnostics Holdings yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

All announcements Monitoring checked today, 10:05

All · 33 Key · 18

Date	Type	Announcement	Day
11 Sep 26	Results	Half-year Results IDH reported 37% revenue growth to EGP 4.9bn in 1H 2026 with 38% EBITDA growth and 47% net profit growth.	+1.2%
04 Sep 26	Routine	Notice of Results
17 Aug 26	Director dealing	Director/PDMR Shareholding
13 Aug 26		Acceptance Level Update Bidco announces closure of mandatory offer for IDH with 56.67% acceptance including Elliott stake.	+2.9%
06 Aug 26		Acceptance Level Update Bidco received acceptances for 7.04% of IDH shares by Day 28, holding 56.66% total including Elliott Transaction shares.	+7.4%
04 Aug 26	Director dealing	Director/PDMR Shareholding
04 Aug 26	Holding	Holding(s) in Company
30 Jul 26		Day 21 Acceptance Level Update Bidco has received acceptances for 7.04% of IDH shares at Day 21 of mandatory offer.	−2.7%
29 Jul 26		Offer Unconditional Mandatory offer by Hena Holdings for IDH now unconditional at US$0.50 per share following 56.6% acceptance.	+9.1%
28 Jul 26		Acceptance Level Update Bidco acquired 49.76% of IDH shares with US$0.50/share offer; 0.14% acceptance from shareholders as of 27 July.	+1.9%
27 Jul 26		Acceptance Level Update Bidco acquires 49.73% acceptance on mandatory offer at US$0.50 per share; offer remains open until 29 July 2026.	+1.9%
24 Jul 26		Acceptance Level Update Unrecommended mandatory offer for Integrated Diagnostics at US$0.50 per share has received minimal acceptances at Day 15.	+0.0%
23 Jul 26		Acceptance Level Update Bidco received no acceptances by day 14 of mandatory 50 cent per share cash offer for IDH.	+2.3%
08 Jul 26		Publication of Offer Document Unrecommended mandatory cash offer for IDH at US$0.50 per share by Bidco, with offer document published and acceptance deadline 29 July 2026.	+1.6%
03 Jul 26	Routine	Form 8 - Integrated Diagnostics Holdings Plc
01 Jul 26	Routine	OPD Rule 8.3 – Integrated Diagnostics Holdings plc
24 Jun 26	Holding	Holding(s) in Company
24 Jun 26	Routine	Form 8 (OPD) - IDH plc
23 Jun 26	Director dealing	Director/PDMR Shareholding
23 Jun 26	Holding	Holding(s) in Company
23 Jun 26		Statement re Mandatory Final Cash Offer Hena Holdings launches mandatory cash offer for IDH at USD0.50 per share following 21.67% stake acquisition.	−11.9%
23 Jun 26		Disclosure Table The following are today's changes to the Disclosure Table:	−11.9%
23 Jun 26		Mandatory Final Cash Offer Hena Holdings announces mandatory cash offer for IDH at $0.50 per share after acquiring 21.67% stake from Elliot.	−11.9%
20 May 26	Results	Replacement - 1st Quarter Results Q1 2026 revenue grew 31% to EGP 2.1bn; net profit rose 78% to EGP 437m despite Ramadan seasonality.	+2.5%
20 May 26	Results	1st Quarter Results Q1 2026 revenue grew 31% to EGP 2.1bn; EBITDA up 23% to EGP 611m with 29.5% margin.	+2.5%
19 May 26	Routine	Result of AGM
30 Apr 26	Routine	Replacement - Holding(s) in Company
23 Apr 26		Annual Financial Report & Notice of AGM Annual Financial Report & Notice of Annual General Meeting	+0.3%
17 Apr 26	Results	Final Results FY 2025 revenue grew 37% to EGP 7.9bn with EBITDA up 61% and adjusted net profit up 79%.	−1.9%
08 Apr 26	Holding	Holding(s) in Company
08 Apr 26	Holding	Holding(s) in Company
13 Nov 25	Results	3rd Quarter Results Integrated Diagnostics reports 41% revenue growth in 9M 2025 with EBITDA margin of 35%, up from 30% prior year.	+20.9%
07 Nov 25	Routine	Notice of Results

Company filings. Not investment advice.